<option id="gefbg"></option>

    <optgroup id="gefbg"><ol id="gefbg"><form id="gefbg"><blockquote id="gefbg"></blockquote></form></ol></optgroup>

    <small id="gefbg"></small>


    International Market

    Hansoh actively implements the internationalization strategy and has been committed itself to human being’s health with its professional expertise, through sales of internationally certified APIs and finished-dose pharmaceutical products to  the U.S. and other countries, and  international multi-center clinical trials for innovative drugs.   

    Market Internationalization 

    Multiple finished-dose pharmaceutical products and APIs are sold to the global market. 

    R&D Internationalization 

    Global multi-center clinical trials are under way simultaneously in the U.S. and China for HS-10296, a Category 1.1 innovative oncology drug, amid efforts for global expansion of innovative drugs.

    时时彩平台哪个好 |2019十大信誉平台最新排行榜 |时时彩平台哪个好官方推荐 | |手机版 | | 新世纪娱乐|澳门线上赌钱网站|百家乐app|正规赌钱游戏平台|凯发电游|澳门赌城网站|